172 results on '"Pichelin, Matthieu"'
Search Results
2. Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19
3. La metformine est associée à une moindre mortalité chez les patients diabétiques hospitalisés pour la COVID-19
4. Diabète et COVID-19 : les leçons de CORONADO
5. A high-throughput mass spectrometry-based assay for large-scale profiling of circulating human apolipoproteins
6. Association between sleep disturbances, fear of hypoglycemia and psychological well-being in adults with type 1 diabetes mellitus, data from cross-sectional VARDIA study
7. Bile acids associate with glucose metabolism, but do not predict conversion from impaired fasting glucose to diabetes
8. Improvement in arterial stiffness (pOpmètre®) after bariatric surgery. Results from a prospective study
9. Circulating PCSK9 levels are not associated with the conversion to type 2 diabetes
10. No association between fear of hypoglycemia and blood glucose variability in type 1 diabetes: The cross-sectional VARDIA study
11. In vivo evidence for transintestinal cholesterol efflux in patients with complete common bile duct obstruction
12. Circulating PCSK9 levels are not associated with the severity of hepatic steatosis and NASH in a high-risk population
13. Phenotypic Differences Between Polygenic and Monogenic Hypobetalipoproteinemia
14. Plasma PCSK9 concentrations during the course of nondiabetic chronic kidney disease: Relationship with glomerular filtration rate and lipid metabolism
15. Association Between Hypoglycemia and the Burden of Comorbidities in Hospitalized Vulnerable Older Diabetic Patients: A Cross-Sectional, Population-Based Study
16. Homozygous Familial Hypercholesterolemia Patients With Identical Mutations Variably Express the LDLR (Low-Density Lipoprotein Receptor): Implications for the Efficacy of Evolocumab
17. Glycaemic control influences the relationship between plasma PCSK9 and LDL cholesterol in type 1 diabetes
18. Phenotypic characteristics and prognosis of newly diagnosed diabetes in hospitalized patients with COVID-19: Results from the CORONADO study
19. Routine use of statins and increased COVID-19 related mortality in inpatients with type 2 diabetes: Results from the CORONADO study
20. Short-term digestive tolerance of chocolate formulated with maltitol in children
21. Influenza vaccination and prognosis of COVID ‐19 in hospitalized patients with diabetes: Results from the CORONADO study
22. Routine use of statins and increased COVID-19 related mortality in inpatients with type 2 diabetes: Results from the CORONADO study
23. Sex disparities in COVID-19 outcomes of inpatients with diabetes: insights from the CORONADO study
24. Routine use of statins and increased mortality related to COVID-19 in inpatients with type 2 diabetes: Results from the CORONADO study
25. Phenotypic Characteristics and Development of a Hospitalization Prediction Risk Score for Outpatients with Diabetes and COVID-19: The DIABCOVID Study
26. Comment on Chen et al. Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication. Diabetes Care 2020;43:1399–1407
27. Type 1 diabetes in people hospitalized for COVID-19: new insights from the CORONADO study
28. Development and automation of 3D innovative hiPSC-based liver organoids including the microenvironment for phenotyping screening - application on metabolic diseases
29. A single procedure to generate functional hiPSCs-derived liver organoids -Towards an innovative tools suitable for drug screening
30. Influenza vaccination and prognosis for COVID‐19 in hospitalized patients with diabetes: Results from the CORONADO study.
31. Fatty liver index is a strong predictor of changes in glycemic status in people with prediabetes: The IT-DIAB study
32. Prevalence and characteristics of Nivolumab-induced diabetes: results from a monocentric observational study
33. Association between sleep disturbances and fear of hypoglycemia in adults with type 1 diabetes, data from VARDIA Study
34. Use of dipeptidyl peptidase‐4 inhibitors and prognosis of COVID‐19 in hospitalized patients with type 2 diabetes: A propensity score analysis from the CORONADO study.
35. Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study.
36. Phenotypic Differences Between Polygenic and Monogenic Hypobetalipoproteinemia.
37. Blood glucose levels and COVID-19. Reply to Sardu C, D'Onofrio N, Balestrieri ML et al [letter] and Lepper PM, Bals R, Jüni P et al [letter].
38. Type 1 Diabetes in People Hospitalized for COVID-19: New Insights From the CORONADO Study.
39. Correction to: Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study.
40. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study.
41. Identification of novel APOB mutations by targeted next-generation sequencing for the molecular diagnosis of familial hypobetalipoproteinemia
42. Prevalence of hypobetalipoproteinemia and related psychiatric characteristics in a psychiatric population: results from the retrospective HYPOPSY Study
43. L’augmentation de la proprotéin convertase subtilisin kexin type 9 (PCSK9) dans le liquide cérébrospinal : un nouveau marqueur associé aux processus neurodégénératifs ?
44. PCSK9 Concentrations in Cerebrospinal Fluid Are Not Specifically Increased in Alzheimer’s Disease
45. THU209 - Development and automation of 3D innovative hiPSC-based liver organoids including the microenvironment for phenotyping screening - application on metabolic diseases
46. PCSK9 cerebrospinal fluid concentrations are not increased in Alzheimer’s disease
47. Plasma cholesterol is excreted in the feces of patients with complete common bile duct obstruction : In vivo evidence for TICE pathway in humans
48. Suivi des patients diabétiques de type 2 traités par pompe à insuline dans le Grand Ouest – Observatoire D2PO
49. Fréquence des hypoglycémies chez les patients diabétiques de type 2 insulinotraités âgés de 75 ans et plus en vie réelle – Description de l’étude HYPOAGE
50. La peur de l’hypoglycémie ne s’associe pas à une plus forte variabilité glycémique chez les sujets présentant un diabète de type 1 – étude VARDIA
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.